• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » GE HealthCare to advance cloud-enabled enterprise imaging through $2.3B Intelerad acquisition

GE HealthCare to advance cloud-enabled enterprise imaging through $2.3B Intelerad acquisition

November 20, 2025 By Sean Whooley

GE HealthCare (Nasdaq: GEHC) announced today that it agreed to acquire Intelerad, a medical imaging software provider, for $2.3 billion.

Chicago-based GE HealthCare plans to complete the deal in cash as it looks to add cloud-enabled and AI-powered imaging solutions. It says the deal furthers its aim to triple its offerings of cloud-enabled products by 2028.

Intelerad provides imaging software and digital enterprise workflow solutions. it has a significant presence in outpatient ambulatory care settings. The company offers cloud-first products designed for radiology and cardiology that span the inpatient and outpatient care settings.

GE HealthCare said Inelerad’s outpatient footprint complements its own leadership in hospital-based imaging. Combined, the company expects these capabilities to create a more comprehensive, cloud-first and AI-enabled imaging offering. It expects this to span diverse care settings, from leading academic medical centers to expanding ambulatory networks.

According to a news release, the deal enables GE HealthCare to expand into a $2 billion-plus growth segment.

More details on the acquisition of Intelerad

GE HealthCare expects Intelerad to deliver $270 million in revenues in its first full year of ownership. Approximately 90% of that registers as recurring, while it expects revenue growth in the low-double-digit range annually, with acceleration under GE HealthCare’s ownership.

Upon close, the company expects an immediately accretive impact to top-line growth and adjusted earnings before interest and taxes (EBIT) margin. It anticipates a slightly dilutive impact to adjusted earnings per share in the short term, inclusive of the impact of financing costs. The company plans to offset this with cost efficiencies. It anticipates a high-single-digit return on invested capital by year five.

The company expects to complete the acquisition in the first half of 2026.

BTIG analysts Ryan Zimmerman and Iseult McMahon maintained a “Buy” rating for GE HealthCare in the wake of the news. They believe the deal “makes sense” for the company, bolstering its recurring revenue offerings.

“Intelerad products can be bundled into larger enterprise-wide transactions for both equipment and software,” they said. “As GE HealthCare pushes to increase use of internally developed AI algorithms within Imaging, we think it will pair well with Intelerad’s suite of products over time, likely accelerating adoption.”

Commentary from company officials

Peter Arduini, president and CEO of GE HealthCare, said:

“As hospital and ambulatory care providers face increased demand for imaging and rising patient volumes, they are looking to simplify and unify their workflows. Our acquisition of Intelerad will bring additional cloud-enabled and intelligent solutions in radiology and cardiology into our portfolio of products and extend our capabilities into outpatient networks, enabling care teams to be more efficient, improve outcomes, and deliver precision care for patients globally. As a result, we expect to accelerate our growth in SaaS products and recurring revenues as we take another evolutionary step to grow into a healthcare solutions provider.”

Roland Rott, president and CEO of Imaging at GE HealthCare, said:

“Intelerad is an outstanding strategic fit and is a pioneer in cloud-based imaging software, with a strong portfolio of world-class solutions across care settings. By combining GE HealthCare’s medical device and AI competence at global scale with Intelerad’s enterprise cloud and imaging expertise, we will be even better positioned to meet the evolving needs of healthcare providers, simplify complex workflows, and drive digital innovation across the industry.”

Jordan Bazinsky, CEO of Intelerad, said:

“Joining GE HealthCare marks an exciting new chapter for Intelerad. GE HealthCare’s global scale and extensive relationships with key decision makers across hospital systems will fuel the expansion of our connected imaging software offering. Together, we look forward to advancing digital innovation in healthcare and delivering more integrated AI-enabled solutions that empower our customers to tackle their greatest challenges.”

Filed Under: Artificial Intelligence (AI), Big Data, Business/Financial News, Digital Health, Electronic Medical Records (EMR), Featured, Health Information Technology, Health Technology, Imaging, Machine Learning (ML), Mergers & Acquisitions, Software / IT Tagged With: GE Healthcare, inteleradmedicalsystems

More recent news

  • Siemens Healthineers completes $44M R&D, manufacturing site expansion
  • Next-gen Apple Watch Ultra 4 includes new health features
  • Johnson & Johnson wins CE mark for new reusable contact lens and other extra medtech news
  • Zimmer Biomet plans to cut 580 jobs in Switzerland
  • Verily Health secures investment from Nvidia to advance healthcare AI platforms

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy